RIGEL PHARMACEUTICALS INC
SOUTH SAN FRANCISCO, CALIFORNIA 940800000
$750K
Total Contract Value
18 awards
First Award
Nov 30, 2022
Last Award
May 21, 2025
Business Size
small
CAGE Code
60TS7
Top Industries (NAICS)
| NAICS Code | Obligations | Awards |
|---|---|---|
| 541715 | $750K | 7 |
| 325412 | $0 | 11 |
Contract Awards
1 awards found
75A50123C00012
Department of Health and Human Services
$750K
Apr 20, 2023
RIGEL PHARMACEUTICALS: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO EVALUATE THE IMPACT OF FOSTAMATINIB TREATMENT DURING HOSPITALIZATION RESULTING FROM ARDS ON LONG-TERM OUTCOMES INCLUDING CLINICAL, BIOMARKER, IMAGING, QOL, FUNCTIONAL AND LUNG FUNCTI
NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2023
Business Details
- UEI
- X7MHPBCMHFM3
- CAGE Code
- 60TS7
- Address
- 1180 VETERANS BLVD
SUITE 900
SOUTH SAN FRANCISCO, CA 940800000 - Congressional District
- CA-15
- Phone
- 6506241135
Parent Company
RIGEL PHARMACEUTICALS INC
Data Source
This profile is based on federal contract award data from USAspending.gov.
View on USAspending.gov